1. Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure?
- Author
-
Mark Kelman, K.D. Altman, and Michael P. Ward
- Subjects
0301 basic medicine ,Male ,Pediatrics ,medicine.medical_specialty ,Parvovirus, Canine ,040301 veterinary sciences ,animal diseases ,viruses ,Vaccines, Attenuated ,Microbiology ,0403 veterinary science ,Parvoviridae Infections ,03 medical and health sciences ,Dogs ,Puppy ,Risk Factors ,biology.animal ,Medicine ,Animals ,Dog Diseases ,Treatment Failure ,Risk factor ,Attenuated vaccine ,General Veterinary ,biology ,business.industry ,Incidence (epidemiology) ,Vaccination ,Canine parvovirus ,Australia ,Outbreak ,Viral Vaccines ,04 agricultural and veterinary sciences ,General Medicine ,biology.organism_classification ,030104 developmental biology ,Immunology ,Female ,business ,Vaccine failure - Abstract
Canine parvovirus (CPV) is a highly contagious and worldwide cause of serious and often fatal disease in dogs, despite the widespread availability of vaccines. Which vaccine-related factors are associated with vaccination failure is largely unknown, and there are no reports from Australia. In this study - the first national population-level CPV study of its kind ever conducted - we analysed data on 594 cases of apparent CPV vaccination failure reported from an Australian national surveillance system to determine whether vaccine strain, type or administration protocol are risk factors for vaccination failures. The strain of CPV used in vaccine manufacture was not significantly associated with vaccination failure in clinical practice. The vaccine type (killed versus attenuated vaccine) for puppies diagnosed with CPV was associated with a lower mean age at time of vaccination (P=0.0495). The age at administration of the last CPV vaccination a puppy received prior to presenting with disease was a significant (P=0.0334) risk factor for vaccination failure, irrespective of whether the vaccine was marketed for a 10-week or 12-week or greater vaccination finish protocol. There was also a strong negative correlation between age at last vaccination prior to disease and vaccination failure (P
- Published
- 2017